Proactively Addressing Complexity in Early Clinical Development

Small and emerging biotechs often rely on the support of a contract research organization (CRO) in early clinical research, but how can both parties ensure they are forming a flexible partnership that can consistently handle the ever-increasing complexity of early clinical development? Through several case studies, this presentation covers: How to ensure your strategies align with your desired endpoints Informing key decision points in early clinical trials Working with adaptive study designs or hybrid designs Tips for planning ahead for unknown issues or changes The importance of a risk management strategy